The need for consensus on delineation and dose constraints of dentofacial structures in paediatric radiotherapy: Outcomes of a SIOP Europe survey.

Contouring Dentofacial Dose-volume constraints Late adverse effects Paediatrics Radiotherapy

Journal

Clinical and translational radiation oncology
ISSN: 2405-6308
Titre abrégé: Clin Transl Radiat Oncol
Pays: Ireland
ID NLM: 101713416

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 14 09 2023
accepted: 21 09 2023
medline: 4 10 2023
pubmed: 4 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

Children receiving radiotherapy for head-and-neck tumours often experience severe dentofacial side effects. Despite this, recommendations for contouring and dose constraints to dentofacial structures are lacking in clinical practice. We report on a survey aiming to understand current practice in contouring and dose assessment to dentofacial structures. A digital survey was distributed to European Society for Paediatric Oncology members of the Radiation Oncology Working Group, and member-affiliated centres in Europe, Australia, and New Zealand. The questions focused on clinical practice and aimed to establish areas for future development. Results from 52 paediatric radiotherapy centres across 27 countries are reported. Only 29/52 centres routinely delineated some dentofacial structures, with the most common being the mandible (25 centres), temporo-mandibular joint (22), dentition (13), orbit (10) and maxillary bone (eight). For most bones contoured, an Routine delineation of dentofacial structures is infrequent in paediatric radiotherapy. Based on survey findings, we aim to 1) define a consensus-contouring atlas for dentofacial structures, 2) develop auto-contouring solutions for dentofacial structures to aid clinical implementation, and 3) carry out treatment planning studies to investigate the importance of delineation of these structures for planning optimisation.

Sections du résumé

Background and purpose UNASSIGNED
Children receiving radiotherapy for head-and-neck tumours often experience severe dentofacial side effects. Despite this, recommendations for contouring and dose constraints to dentofacial structures are lacking in clinical practice. We report on a survey aiming to understand current practice in contouring and dose assessment to dentofacial structures.
Methods UNASSIGNED
A digital survey was distributed to European Society for Paediatric Oncology members of the Radiation Oncology Working Group, and member-affiliated centres in Europe, Australia, and New Zealand. The questions focused on clinical practice and aimed to establish areas for future development.
Results UNASSIGNED
Results from 52 paediatric radiotherapy centres across 27 countries are reported. Only 29/52 centres routinely delineated some dentofacial structures, with the most common being the mandible (25 centres), temporo-mandibular joint (22), dentition (13), orbit (10) and maxillary bone (eight). For most bones contoured, an
Conclusion UNASSIGNED
Routine delineation of dentofacial structures is infrequent in paediatric radiotherapy. Based on survey findings, we aim to 1) define a consensus-contouring atlas for dentofacial structures, 2) develop auto-contouring solutions for dentofacial structures to aid clinical implementation, and 3) carry out treatment planning studies to investigate the importance of delineation of these structures for planning optimisation.

Identifiants

pubmed: 37790584
doi: 10.1016/j.ctro.2023.100681
pii: S2405-6308(23)00106-4
pmc: PMC10543782
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100681

Informations de copyright

© 2023 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Med Internet Res. 2021 Jul 12;23(7):e26151
pubmed: 34255661
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):669-679
pubmed: 30414451
Radiother Oncol. 1999 Nov;53(2):143-8
pubmed: 10665792
N Engl J Med. 2006 Oct 12;355(15):1572-82
pubmed: 17035650
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):635-42
pubmed: 21377294
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Int J Radiat Oncol Biol Phys. 2021 May 29;:
pubmed: 34074567
Radiother Oncol. 2015 Oct;117(1):83-90
pubmed: 26277855
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):e151-5
pubmed: 23273995
Radiat Oncol. 2014 Dec 29;9:264
pubmed: 25544268
Int J Oral Maxillofac Surg. 2023 Jul;52(7):787-792
pubmed: 36328865
J Clin Oncol. 2012 Jul 10;30(20):2466-74
pubmed: 22614987
Radiother Oncol. 2019 Jan;130:56-61
pubmed: 30420234
Pract Radiat Oncol. 2020 Jan - Feb;10(1):53-58
pubmed: 31629089
Dentomaxillofac Radiol. 2015;44(7):20150034
pubmed: 25812046
Med Sci Monit. 2014 Dec 04;20:2536-42
pubmed: 25473782
J Med Radiat Sci. 2023 Apr;70 Suppl 2:15-25
pubmed: 36148621
Pediatr Blood Cancer. 2016 Sep;63(9):1608-14
pubmed: 27195454
Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):108-13
pubmed: 23332385
Eur J Cancer. 2003 Jul;39(11):1594-602
pubmed: 12855267
Proc R Soc Med. 1959 Apr;52(4):263-8
pubmed: 13645654
Cancer Radiother. 2023 Apr;27(2):103-108
pubmed: 36739196
Pediatrics. 2020 May;145(5):
pubmed: 32284427
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
Radiat Oncol. 2013 Jun 26;8:154
pubmed: 23803232
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Apr;127(4):272-281
pubmed: 30685390
Phys Med. 2022 Jul;99:31-43
pubmed: 35609381
Pediatr Dent. 1993 Jan-Feb;15(1):6-12
pubmed: 8233995
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1330-1338
pubmed: 30061005

Auteurs

Angela Davey (A)

Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Shermaine Pan (S)

Department of Proton Therapy, The Christie NHS Foundation Trust, Manchester, UK.

Abigail Bryce-Atkinson (A)

Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Henry Mandeville (H)

The Royal Marsden NHS Foundation Trust, London, UK.

Geert O Janssens (GO)

Princess Maxima Center for Paediatric Oncology, Utrecht, The Netherlands.
Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

Sarah M Kelly (SM)

European Society for Paediatric Oncology (SIOP Europe), Clos Chapelle-aux-Champs 30, Brussels, Belgium.
The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Avenue E. Mounier 83, Brussels, Belgium.
Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Marinka Hol (M)

Princess Maxima Center for Paediatric Oncology, Utrecht, The Netherlands.
Department of Otorhinolaryngology, University Medical Center Utrecht, Utrecht, The Netherlands.

Vivian Tang (V)

Paediatric Radiology, Royal Manchester Children's Hospital, Manchester, UK.

Lucy Siew Chen Davies (LSC)

Department of Radiotherapy, The Christie NHS Foundation Trust, Manchester, UK.
European Society for Paediatric Oncology (SIOP Europe), Clos Chapelle-aux-Champs 30, Brussels, Belgium.

Marianne Aznar (M)

Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Classifications MeSH